首页> 外国专利> NOVEL METABOLITES OF VANOXERINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RHYTHM IN MAMMALS

NOVEL METABOLITES OF VANOXERINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RHYTHM IN MAMMALS

机译:Vanoxerine化合物的新代谢物,包含相同成分的药物成分以及终止急性心律失常的方法,恢复正常窦性心律,预防心律失常的复发和维持生命的方法

摘要

Disclosed embodiments are related to pharmaceutical compositions comprising novel piperazine compounds and methods of administration of the same to a patient for termination of acute episodes of cardiac arrhythmias, maintaining normal sinus rhythm, restoring normal sinus rhythm, and preventing recurrence of cardiac arrhythmia.
机译:公开的实施方案涉及包含新型哌嗪化合物的药物组合物及其向患者给药以终止心律不齐的急性发作,维持正常的窦性心律,恢复正常的窦性心律以及防止心律不齐的复发的方法。

著录项

  • 公开/公告号WO2014176497A1

    专利类型

  • 公开/公告日2014-10-30

    原文格式PDF

  • 申请/专利权人 CHANRX CORPORATION;

    申请/专利号WO2014US35447

  • 发明设计人 BROWN ARTHUR M.;

    申请日2014-04-25

  • 分类号A61K31/4965;A61K31/496;A61P9;

  • 国家 WO

  • 入库时间 2022-08-21 15:46:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号